Scientific Program

/Scientific Program
Scientific Program 2018-11-11T17:25:54+00:00

Day 1, Friday, November 16, 2018

Good morning – Welcome Coffee, served prior to the start of the day
8:30 a.m. – 9:15 a.m. Opening Session
8:30 a.m. – 8:45 a.m. Welcome and announcement of the “Young Investigator Award”
Norbert Gleicher, MD and David F. Albertini, PhD
8:45 a.m. – 9:15 a.m. The “Breaking News” lecture
Understanding translational dysfunction in fragile X-associated neural and reproductive disorders.*
Ethan J. Greenblatt, PhD
*this talk is based on Greenblatt & Spradling, Science 2018; 361;709-712
9:15 a.m. – 11:15 a.m. Session 1 – Plenary: Where our journey is leading to – Part I
Chairs: David F. Albertini, PhD and Norbert Gleicher, MD
9:15 a.m. – 9:45 a.m. Beyond tech support: What physics brings to biology
Eric D. Siggia, PhD
9:45 a.m. – 10:15 a.m. Maneuvering between ethical concerns and the desire to advance science
Eli Y. Adashi, MD, MS, MA
10:15 a.m. – 10:45 a.m. Increased mTOR activity in FMR1 knockout mice and premature recruitment of oocyte pool reversed with rapamycin
S. Zev Williams, MD, PhD
10:45 a.m. – 11:15 a.m. How the FMR1 gene and the AKT/mTOR signaling pathways potentially control folliculogenesis
Julia Rehnitz, MD
11:15 a.m. – 11:45 a.m. Coffee Break, Poster Viewing & Visit the Exhibition
11:45 a.m. – 12:45 p.m. Session 2 – Plenary: Where our journey is leading to – Part II
Chairs: Neeta Singh, MD and Zeev Shoham, MD
11:45 a.m. – 12:15 p.m. A first step in growing human primordial follicles in vitro to maturity in a multi-step culture system
Evelyn E. Telfer, PhD
12:15 p.m. – 12:45 p.m. Combining imaging and transcriptomics at single cell resolution to understand blastocyst formation
Anna-Katerina Hadjantonakis, PhD
12:45 p.m. – 1:00 p.m. Get your lunch “to-go”
1:00 p.m. –2:00 p.m. Lunch break debate – bring your lunch

Chair: Norbert Gleicher, MD

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

– Very effective: Nicole Noyes, MD

– Not very effective: Vitaly A. Kushnir, MD

2:00 p.m. – 3:30 p.m. Session 3 – Paradigm change I: Clarifying the significance of chromosomal abnormalities in human embryos
Chairs: Evelyn E. Telfer, PhD and Vitaly A. Kushnir, MD
2:00 p.m. – 2:30 p.m. When chromosomal abnormalities are the norm
Rajiv C. McCoy, PhD
2:30 p.m. – 3:00 p.m. Explaining the purpose of PGS/PGT-A
Nathan R. Treff, PhD
3:00 p.m. – 3:30 p.m. Explaining the shortcomings of PGS/PGT-A
Raoul Orvieto, MD
3:30 p.m. – 4:00 p.m. Coffee Break, Poster Viewing & Visit the Exhibition
4:00 p.m. – 6:00 p.m. Session 4 – Paradigm change II: Changing the thinking about PCOS
Chairs: Nicole Noyes, MD and Raoul Orvieto, MD
4:00 p.m. – 4:30 p.m. Why new diagnostic criteria for different PCOS phenotypes are urgently needed
Ricardo Azziz, MD, MPH, MBA
4:30 p.m. – 5:00 p.m. Using AMH to diagnose PCOS?
Neeta Singh, MD
5:00 p.m. – 5:30 p.m. A surprisingly common new hypo-androgenic PCOS-like phenotype
Norbert Gleicher, MD
5:30 p.m. – 6:00 p.m. Evidence for existence of a pituitary-adrenal-ovarian axis that controls ovarian function
Vitaly A. Kushnir, MD

Day 2, Saturday, November 17, 2018

Good morning – Welcome Coffee, served prior to the start of the day
8:30 a.m. – 10:30 a.m. Session 5 – Plenary: Where our journey is leading to – Part III
Chairs: Eli Y. Adashi, MD, MS, MA and Ricardo Azziz, MD, MPH, MBA
8:30 a.m. – 9:00 a.m. “Sensing of the whole”: Morphodynamics of early embryo development
Ilya Volodayev, PhD
9:00 a.m. – 9:30 a.m. Genomic evidence for the importance of inflammation on IVF outcomes
Marc-André Sirard, DMV, PhD
9:30 a.m. – 10:00 a.m. E2F1-mediated epigenetic mechanism in ovarian response controls FMR1 expression in human granulosa cells
Julia Rehnitz, PhD
10:00 a.m. – 10:30 a.m. What autologous stem cell transplants are effective in the treatment of refractory Asherman’s syndrome?
Neeta Singh, MD
10:30 a.m. – 11:00 a.m. Coffee Break, Poster Viewing & Visit the Exhibition
11:00 a.m. – 12:00 p.m. Session 6 – Plenary: Where our journey is leading to – Part IV
Chairs: Marc-André Sirard, DMV, PhD and Julia Rehnitz, PhD
11:00 a.m. – 11:30 a.m. Targeting mTOR signaling to preserve reproductive longevity
Kara N. Goldman, MD
11:30 a.m. – 12:00 p.m. Correlating micropattern differentiation of mouse pluripotent stem cells with mouse embryos, to inform human embryo cell fate patterning
Anna-Katerina Hadjantonakis, PhD
12:00 p.m. – 12:15 p.m. Get your lunch “to-go”
12:15 p.m. – 1:15 p.m. Lunch break debate – bring your lunch

Chair: David H. Barad, MD, MS

When is the right time to refer a patient into egg donation?

– Above the age 42 and/or FSH 15.0-20.0 mIU/mL: Eli Y. Adashi, MD, MS, MA

– It should always be the patients’ choice: Norbert Gleicher, MD

1:15 p.m. – 3:00 p.m. Session 7 – Paradigm change III: Individualizing IVF practice for best outcome by age and functional ovarian reserve
Chairs: Kara N. Goldman, MD and Pasquale Patrizio, MD, MS
1:15 p.m. – 1:35 p.m. Why follicles need adequate androgen levels
Andrea Weghofer, MD, PhD, MS, MBA
1:35 p.m. – 1:55 p.m. How to supplement hypo-androgenic women correctly
Norbert Gleicher, MD
1:55 p.m. – 2:15 p.m. The intra-follicular molecular biology mandating advancement of egg retrieval in some women
David H. Barad, MD, MS
2:15 p.m. – 2:35 p.m. HIER – Highly individualized egg retrieval
Vitaly A. Kushnir, MD
2:35 p.m. – 2:55 p.m. Carrying over individualization of care into the embryology laboratory
David F. Albertini, PhD
3:00 p.m. – 3:30 p.m. Coffee Break, Poster Viewing & Visit the Exhibition
3:30 p.m. – 5:30 p.m. Session 8 – Plenary: Hidden treasures discovered
Chairs: Andrea Weghofer, MD, PhD, MS, MBA and David H. Barad, MD, MS
3:30 p.m. – 4:00 p.m. Modelling human embryology in a dish
Mijo Simunovic, PhD
4:00 p.m. – 4:30 p.m. Can tacrolimus treatment affect pregnancy outcomes in presence of maternal immune abnormalities?
Frederick W. K. Kan, PhD
4:30 p.m. – 5:00 p.m. An immune clock that controls pregnancy
Brice Gaudilliere, MD, PhD
5:00 p.m. – 5:30 p.m. A new frontier in the IVF laboratory: Automatic vitrification of oocytes and embryos
Pasquale Patrizio, MD, MS

Day 3, Sunday, November 18, 2018

Good morning – Welcome Coffee, served prior to the start of the day
9:00 a.m. – 10:30 a.m. Session 9 – Plenary: Hot topics
Chairs: Zeev Shoham, MD and John Zhang, MD, MSc, PhD
9:00 a.m. – 9:30 a.m. Oogonial stem cells after all?
Evelyn E. Telfer, PhD
9:30 a.m. – 10:00 a.m. Stem cells and in the treatment of human infertility
Sherman J. Silber, MD
10:00 a.m. – 10:30 a.m. Nuclear transfer: History and potential application in human reproduction
John Zhang, MD, MSc, PhD
10:30 a.m. – 11:00 a.m. Coffee Break
11:00 a.m. – 1:00 p.m. Closing Session: Most Interesting recent 2018 presentations and yet unpublished data
Chairs: David F. Albertini, PhD and Norbert Gleicher, MD
11:00 a.m. – 11:20 a.m. The evolving potential translational importance of cumulin (GDF9: BMP15) treatments for female fertility
Aritro Sen, PhD
11:20 a.m. – 11:40 a.m. Does platelet-rich (autologous) plasma (PRP) “rejuvenate” ovaries and endometrium?
Andrea Weghofer, MD, PhD, MS, MBA
11:40 a.m. – 12:00 p.m. Human blastocysts of normal and abnormal karyotypes display distinct transcriptome profiles
Frederick L. Licciardi, MD
12:00 p.m. – 12:20 p.m. Transferring chromosomally “abnormal embryos” after PGS/PGT-A: a worldwide survey of IVF centers by www.IVF-Worldwide.com
Pasquale Patrizio, MD, MS
12:20 p.m. – 1:00 p.m. The FRMC Closing Lecture
Will human embryos fly and more?
Ali H. Brivanlou, PhD
1:00 p.m. Closing Remarks
Norbert Gleicher, MD